If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
449.50    -5.50 (-1.21%)
Bid:
449.50
Ask:
458.00
Spread: 8.50 (1.891%)
Market Cap: £221.07m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Trading Update

4 Nov 2025 07:00

RNS Number : 0094G
Zotefoams PLC
04 November 2025
 

Zotefoams plc

("Zotefoams" or "Group")

 

Trading Update

"Continued good strategic progress - trading in line with expectations"

4 November 2025 - Zotefoams, a world leader in supercritical foams, today provides a trading update for the three months ended 30 September 2025 ("Q3" or the "period") and in respect of its financial year ending 31 December 2025.

The Group has sustained its positive trading momentum during the period, delivering a performance in line with the Board's expectations.

Following a record first half, the Group achieved Q3 reported revenue of £38.2m (Q3 2024: £39.7m), which was in line with a very strong prior year comparator on a constant currency basis:

·

EMEA revenue in Q3 reduced 1% with the anticipated moderation and seasonality in Consumer & Lifestyle largely offset by ongoing strong demand in Transport & Smart Technologies, as well as growth in the Construction & Other Industrial insulation business.

·

North America revenue in Q3 was down 16%, following a strong H1, largely due to phasing of orders in Transport & Smart Technologies, and more subdued demand in Construction & Other Industrial.

·

The Asia region, though currently representing a small portion of revenue at £1.1m, saw good growth in the period and remains strategically important as the Group continues preparations for operations in Vietnam, a key market for the Consumer & Lifestyle vertical.

 

On a year-to-date basis, Group reported revenue is up 5% to £115.7m (YTD 2024: £110.7m), and up 7% on a constant currency basis:

·

Year-to-date EMEA revenue was up 7%. Within this Consumer & Lifestyle was up 7%, driven by strong demand from Nike in the first half of the year to support strategic stocking in advance of planned product launches. Construction & Other Industrial was up 15%, with ongoing demand in the UK market and stronger demand for insulation in Q3. Transport & Smart Technologies was up 4%, reflecting sustained momentum in our target sectors.

·

Year-to-date North America revenue was in line with the prior year, with good growth in Transport & Smart Technologies, up 16%, reflecting success in aerospace and specialty packaging. This was offset by lower demand in Construction & Other Industrial, down 12%, reflecting demand headwinds as well as repositioning of our channel partners.

·

In Asia, our smallest region by sales, year-to-date performance has been driven by our T-FIT® insulation business, which is up 5%, offset by the non-repeat of several larger one-off sales in Transport & Smart Technologies in the prior year

 

Year-to-date Gross margin reflects the sales profile and is in line with the prior year, with the benefit of the revenue growth and the closure of MELs operating activities.

The balance sheet remains strong with good cashflow from operations reflecting our ongoing focus on working capital and leverage of 0.5x (Q3 2024 0.9x).

Strategy progress:

The Group has continued to make excellent progress on its strategic initiatives during Q3:

·

Brandon Thomas was appointed as Managing Director, Asia - bringing extensive technical and commercial experience from his role as General Manager, Asia at Nike, where he established their Air Manufacturing Innovation facility in Vietnam.

·

In August, the Group announced its partnership with Seoheung Co. Ltd. a footwear supply chain specialist, through a joint venture for the Vietnam manufacturing facility. Seoheung is investing $10m for a 17.5% stake, significantly de-risking this investment from both financial and technical perspectives.

·

The Group signed a lease in South Korea for the new footwear innovation hub, which will further strengthen Zotefoams' capabilities and customer relationships in the athletic footwear market.

·

The Group committed to the establishment of a global innovation centre at its Croydon facility, which will form a platform into which R&D capabilities can be consolidated to accelerate product development across all three market verticals.

·

The development of the Group's new manufacturing facility in Vietnam continues as planned, with commissioning expected in Q4 2026. This facility will position the Group significantly closer to a key global footwear manufacturing hub.

·

In North America, the second low-pressure vessel was successfully commissioned, providing enhanced capacity to support future growth in the region.

·

In December 2024, Zotefoams paused investment in its ReZorce® circular packaging technology. As a result, Zotefoams has not committed further financial investment or resource to the development of ReZorce and has no plans to do so. The Group has remained open to enabling interested parties to complete the development and achieve commercialisation of the technology. A consortium of investors, including the former Zotefoams business lead for ReZorce, has formed a company called ReZorce Limited, with no ties to Zotefoams plc, to explore this opportunity. Zotefoams has assigned certain intellectual property rights to ReZorce Limited, while retaining control over the IP until commercialisation, and supported them in the decommissioning of the asset in Denmark and transporting it to their preferred destination. The Group does not expect to receive any consideration for this, nor provide any ongoing financial assistance to the consortium, but has retained the right to receive a cost-free minority stake in the business should it succeed.

 

Outlook

The Board is confident in the Group's ability to sustain positive momentum, with good visibility of confirmed orders across most business units for the remainder of the final quarter, underpinning a continued expectation of delivering mid-single-digit growth for the year as a whole.

Based on current sales forecasts and foreign exchange rates, and subject to there being no material disruption to key markets, the Board expects revenue and adjusted profit before tax for 2025 to be in line with current market expectations*.

Commenting on the update Ronan Cox, Group CEO of Zotefoams, said: 

"In what remain mixed market conditions, I am pleased that the business has continued to trade in line with our expectations, whilst also making good progress with our refreshed strategy.

Our commercial transformation into market-focused verticals continues to progress well, with our pipeline of opportunities growing across all three sectors.

The strategic progress we have made this year has been exceptional. Our partnership with Seoheung in Vietnam, the appointment of Brandon Thomas to lead our Asian operations, the signing of our South Korea footwear innovation hub lease, and the plan for the establishment our Croydon innovation centre all demonstrate our commitment to positioning Zotefoams for long-term sustainable growth. These investments in capability, capacity, and customer proximity are already strengthening our relationships with key partners and expanding our market opportunities.

Looking ahead, our order book provides good visibility for the remainder of 2025 and as a result, the Board remains confident in its ability to meet market expectations for the full year."

* Current Zotefoams-compiled consensus expectations for revenue is £154.4m and adjusted profit before income tax and separately disclosed items, for the year ending 31 December 2025, is £20.5m.

 

- Ends -

 

 

Enquiries:

 

Zotefoams plc

Ronan Cox, Group CEO

Nick Wright, Group CFO

 

+44 (0) 208 664 1600

IFC Advisory

Graham Herring

Tim Metcalfe

Zach Cohen

+44 (0) 203 934 6630

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in supercritical fluid foam technology, delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide across three market verticals, Consumer & Lifestyle, Transport & Smart Technologies, and Construction & Other Industrial. Zotefoams uses its own materials to manufacture T-FIT® advanced insulation for demanding industrial markets.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), and foam products conversion in Oklahoma, USA and Jiangsu Province, China (T-FIT).

AZOTE®, ZOTEK®, and T-FIT® are registered trademarks of Zotefoams plc.

www.zotefoams.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFZMGMLFMGKZM
Date   Source Headline
8th Sep 20153:56 pmRNSDirector/PDMR Shareholding
7th Aug 20159:00 amRNSDirector/PDMR Shareholding
4th Aug 20157:00 amRNSHalf Yearly Report
10th Jul 20157:00 amRNSTrading Update
9th Jul 201511:38 amRNSHolding(s) in Company
2nd Jul 20157:30 amRNSDirector Declaration
23rd Jun 20154:08 pmRNSHolding(s) in Company
22nd Jun 20154:58 pmRNSHolding(s) in Company
22nd Jun 20152:39 pmRNSHolding(s) in Company
27th May 20158:57 amRNSHolding(s) in Company
13th May 20153:00 pmRNSResult of AGM
13th May 20157:00 amRNSAGM Trading Update
13th Apr 20153:22 pmRNSDirector/PDMR Shareholding
10th Apr 20159:30 amRNSAnnual Report and Notice of AGM
31st Mar 20159:26 amRNSDirector/PDMR Shareholding
30th Mar 201510:55 amRNSHolding(s) in Company
27th Mar 20153:32 pmRNSHolding(s) in Company
23rd Mar 20158:40 amRNSHolding(s) in Company
17th Mar 20157:00 amRNSFinal Results
11th Mar 20153:51 pmRNSNew venture with China-based King Lai Group
16th Jan 20154:18 pmRNSNotification of Major Interest in Shares
9th Jan 20158:47 amRNSHolding(s) in Company
7th Jan 20157:00 amRNSTrading Update
7th Nov 20147:00 amRNSInterim Management Statement
20th Oct 20147:01 amRNSDirector Declaration
6th Oct 20142:07 pmRNSDirector/PDMR Shareholding
25th Sep 20147:00 amRNSAppointments of Non-executive Directors
19th Sep 201410:31 amRNSHolding(s) in Company
19th Sep 201410:30 amRNSHolding(s) in Company
17th Sep 20149:45 amRNSDirector/PDMR Shareholding
17th Sep 20149:41 amRNSTotal Voting Rights
16th Sep 20144:45 pmRNSHolding(s) in Company
12th Sep 20147:00 amRNSPlacing to raise approximately £8.8m
12th Aug 20147:00 amRNSHalf Yearly Report
29th Jul 201411:17 amRNSHolding(s) in Company
30th Jun 20147:00 amRNSTrading Statement
20th May 201412:59 pmRNSResult of AGM
19th May 20147:00 amRNSAGM Statement and Interim Management Statement
13th May 20143:31 pmRNSDirectorate Change
22nd Apr 201412:41 pmRNSUnilever to use MuCell technology for Dove bottles
14th Apr 20144:04 pmRNS2013 Annual Report & Accounts and Notice of AGM
9th Apr 20149:06 amRNSDirector/PDMR Shareholding
8th Apr 20148:16 amRNSDirector/PDMR Shareholding
18th Mar 20147:00 amRNSFinal Results
15th Jan 20147:00 amRNSTrading Update
19th Nov 20134:19 pmRNSHolding(s) in Company
23rd Oct 20137:00 amRNSTrading Update and Interim Management Statement
17th Oct 20131:21 pmRNSHolding(s) in Company
1st Oct 20132:13 pmRNSDirector Declaration
21st Aug 201312:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.